Characteristics and effects of female hormones used by male transsexuals in Lima, Peru

Descripción del Articulo

Introduction: In the feminization process, some male transsexuals use synthetic female hormones whose safety has not been defined in genetically male persons. Objectives: To evaluate the degree of knowledge, frequency of use, type of administration, adverse effects and source of information on femal...

Descripción completa

Detalles Bibliográficos
Autores: Sánchez, Sixto, Casquero, Jorge, Chávez, Susana, Liendo, George
Formato: artículo
Fecha de Publicación:2014
Institución:Universidad Nacional Mayor de San Marcos
Repositorio:Revistas - Universidad Nacional Mayor de San Marcos
Lenguaje:español
OAI Identifier:oai:ojs.csi.unmsm:article/10844
Enlace del recurso:https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/10844
Nivel de acceso:acceso abierto
Materia:Transexualismo
feminización
hormonas femeninas gonadales
Descripción
Sumario:Introduction: In the feminization process, some male transsexuals use synthetic female hormones whose safety has not been defined in genetically male persons. Objectives: To evaluate the degree of knowledge, frequency of use, type of administration, adverse effects and source of information on female hormones in male transsexual persons. Design: Qualitative and quantitative community prospective study. Place: Lima. Participants: Male transsexuals 18 years old or older who had been using female hormones for 6 months or more. Interventions: Four trained male transsexuals identified new male transsexual by the ‘snow ball’ method. Then, subjects were interviewed, underwent physical examination, and a 10 mL blood sample was obtained. Main outcome measures: Level of knowledge, quality of information received, acquisition source, and side effects of female hormones. Results: Only 11.8% of the participants obtained the hormones by medical prescription and had some knowledge about its effects. Most common side effects were breast tenderness and weight gain (88.2%), and decline of libido and erection (58.8%). A combination of dihydroxyprogesterone plus estriol IM was the most common female hormone used (47.1%). Conclusions: Implementation of multidisciplinary services that meet the health needs of this population is necessary to decrease the risks.
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).